Please login to the form below

Not currently logged in
Email:
Password:

Q2 results 2012

This page shows the latest Q2 results 2012 news and features for those working in and with pharma, biotech and healthcare.

Lexapro generics hammer Forest Labs' Q3 results

Lexapro generics hammer Forest Labs' Q3 results. Sales down by nearly 40 per cent. ... Forest Laboratories saw sales in the third quarter of 2012 drop almost 40 per cent on the back of generic competition to its Lexapro antidepressant, which lost patent

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics